Theraputic effects of chondroitin sulfate and glucosamine sulphate mixture on Kaschin-Beck Disease : a randomised, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-08000140

Enrollment

Unknown

Registered

2008-07-07

Start date

2007-07-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Kaschin-Beck disease.

Interventions

Control group:Take placebo

Treatment group:chondroitin sulfate and glucosamine sulphate mixture

Eligibility

Sex/Gender

All

Age

40 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with Kashcin-beck disease elder than 40 years without other bone and cartilage correlated diseases, and without the diseases may influence metabolism.

Exclusion criteria

Exclusion criteria: History or active presence of other bone or cartilage disease and an illness known to affect bone metabolism (i.e., Paget's disease, osteoporosis, osteomalacia, cancer or alcoholism); traumatic knee lesions; substantial abnormalities in haematological, hepatic, renal.

Design outcomes

Primary

Measure	Time frame
Three sulphate unsaturated disaccharides in urine;Hydroxyproline in urine;Pyridinoline level in patients' urine;Mean knee joint-space width;	—

Countries

China

Contacts

Public ContactJianbo Yang

yjb1926@126.com+86 0451 87503115

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026